Page last updated: 2024-09-04

gadolinium dtpa and losartan potassium

gadolinium dtpa has been researched along with losartan potassium in 1 studies

Compound Research Comparison

Studies
(gadolinium dtpa)
Trials
(gadolinium dtpa)
Recent Studies (post-2010)
(gadolinium dtpa)
Studies
(losartan potassium)
Trials
(losartan potassium)
Recent Studies (post-2010) (losartan potassium)
12,6546644,05124,3902,4935,408

Protein Interaction Comparison

ProteinTaxonomygadolinium dtpa (IC50)losartan potassium (IC50)
Bile salt export pumpHomo sapiens (human)8.53
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0082
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0049
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0082
5-hydroxytryptamine receptor 1AMus musculus (house mouse)0.0082
Type-1 angiotensin II receptorCavia porcellus (domestic guinea pig)0.018

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brasch, RC; Chaopathomkul, B; Herfkens, RJ; High, WA; Hope, TA; Leboit, PE; Rogut, VS1

Other Studies

1 other study(ies) available for gadolinium dtpa and losartan potassium

ArticleYear
Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron.
    Radiology, 2009, Volume: 253, Issue:2

    Topics: Animals; Calcium; Contrast Media; Drug Synergism; Epoetin Alfa; Erythropoietin; Gadolinium DTPA; Injections, Intravenous; Iron-Dextran Complex; Male; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Wistar; Recombinant Proteins; Skin

2009